SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Daily Briefing

AI Roundup: ChatGPT's business tier is officially here


OpenAI launches a new version of ChatGPT that promises “enterprise-grade security and privacy,” a new study shows AI can write surgery notes in just 5 seconds, and more, in this week's roundup of AI-related stories from Advisory Board's Thomas Seay.

ChatGPT's business tier is officially here. Up until now, many organizations have banned employees from using OpenAI's ChatGPT due, in part, to concerns about data privacy. Now, OpenAI is tackling the problem head-on: It's launched ChatGPT Enterprise, which promises “enterprise-grade security and privacy” and pledges not to train its models on users' data. If you're wondering how much all this will cost, keep wondering: Brad Lightcap, the company's COO, would say only that pricing “will depend, for us, on every company's use cases and size.”

  • Healthcare implications: Although reporting is sketchy, it appears ChatGPT Enterprise does not  meet HIPAA requirements—a limitation that may continue to impede healthcare industry use. That said, plenty of healthcare organizations handle data that is sensitive but not HIPAA-protected, which may be well-suited to using with ChatGPT Enterprise.

AI slashes the time to write operative notes by 99%. For a new study in the Mayo Clinic Proceedings: Digital Health, four plastic surgeons began using ChatGPT to generate their operative notes. The results? ChatGPT wrote each operative note in just five seconds, compared to more than seven minutes for human-written notes. 100% of ChatGPT's outputs complied with current guidelines, and both patients and doctors were satisfied with the results. Intriguingly, the authors also experimented with adding AI-generated images to operative notes, “show[ing] the potential for AI to add value to medical documentation and improve the quality of care provided to patients.” Here's one example:

Who owns the copyright in AI-created content? The U.S. Copyright Office is asking the public to weigh in on big issues surrounding copyright and AI. Among the questions: Does “fair use” allow AI companies to train their models using copyrighted content? If a human partners with AI to create a new document, who owns its copyright? What if the AI operates without any human support at all?

Google: Political ads must disclose AI-generated content. In advance of next year's elections, Google has announced a new policy requiring political advertisers to prominently disclose any use of “synthetic content,” such as AI-generated images and videos. It's an early indication of how search engines are trying to stem a potential flood of fake imagery.

A deeply reported, behind-the-scenes look at OpenAI. Steven Levy, editor at large at Wired, has reported for many years on the top figures at OpenAI, including CEO Sam Altman. Now, he takes a deep dive into the company and its mind-bogglingly grand ambitions, which go so much farther than just building a chatbot. As Levy makes clear, OpenAI's ultimate aim is to create an artificial superintelligence, which it hopes will … well, solve all human problems and usher in utopia. Fingers crossed.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

Thomas Seay

Managing director

TOPICS

INDUSTRY SECTORS

Related Resources

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.